Tag: tumor microenvironment and immune response

Non-small cell lung cancer (NSCLC) remains one of the most challenging cancers to treat effectively, with a significant need for ...

In the relentless pursuit of effective cancer therapies, novel research has emerged, casting fresh light on the metabolic processes within ...

Early-phase clinical data are increasingly shedding light on groundbreaking therapeutic strategies that harness the body's own immune defenses to combat ...

In the intricate battle against breast cancer, immune cells residing within tumors—known as tumor-infiltrating lymphocytes (TILs)—play a critical role in ...

In recent years, the intricate relationship between tumor biology and immune response has garnered significant attention, especially in the realm ...

In recent years, the treatment paradigm for non-small-cell lung cancer (NSCLC) has undergone a transformative shift, primarily driven by the ...

Lactic acid, once dismissed as a mere metabolic byproduct of glycolysis, has emerged as a potent and multifaceted regulator within ...

The Prognostic Power of Systemic Inflammation in Immunotherapy for Non-Small Cell Lung Cancer: New Meta-Analytical Insights Lung cancer remains a ...

A groundbreaking discovery from a collaborative team at the University of Chicago and the University of Pittsburgh has unveiled a ...

Research has unveiled groundbreaking insights into a novel antibody treatment that enhances the immune response of patients battling ovarian cancer. ...